Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

December 21, 2024

Study Completion Date

December 21, 2024

Conditions
HealthyDementiaAlzheimer DiseasePhysical Activity
Interventions
BEHAVIORAL

Physical Activity Condition

Subjects will attend virtual group exercise sessions 3x/week for 1 year. Each subject will be encouraged to walk at a moderate intensity (target heart rate (HR)= 40-59% HR reserve) dependent on resting HR and age. Subjects will perform aerobic exercise on their own and resistance exercises will be completed in virtual exercise sessions with an instructor 1 hour/day for 3 days/week for 1 year. At the exercise sessions, these participants will be asked to record measures of the exercises completed and may be asked to provide measures of heart rate (assessed by palpation for 20-seconds) and rate of perceived exertion (RPE). They will be asked to submit exercise logs providing this information. Data from exercise logs and exercise specialist records will be reviewed for evidence of progression, consistent attainment of moderate intensity, and with respect to the prescribed duration of the aerobic and strength training components.

Trial Locations (1)

27402

University of North Carolina-Greensboro, Greensboro

All Listed Sponsors
collaborator

Wake Forest University Health Sciences

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

University of North Carolina, Greensboro

OTHER

NCT03876314 - Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype | Biotech Hunter | Biotech Hunter